5,777
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Real-world switching patterns and associated characteristics in patients with psoriasis treated with biologics in the United States

ORCID Icon, , , , & ORCID Icon
Article: 2200870 | Received 03 Feb 2023, Accepted 22 Mar 2023, Published online: 16 May 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lluís Rusiñol, Elena Carmona-Rocha & Lluís Puig. (2023) Durability and long-term outcomes of biologic therapies in psoriasis. Expert Review of Clinical Immunology 0:0, pages 1-12.
Read now

Articles from other publishers (3)

Chang‐Yu Hsieh, Yu‐Hsian Tseng & Tsen‐Fang Tsai. (2023) Predictors for the effectiveness of 75 mg risankizumab in treating psoriasis—A real‐word evidence from a 52‐week retrospective study. Experimental Dermatology 32:12, pages 2138-2148.
Crossref
Sara Mucherino, Concetta Rafaniello, Marianna Serino, Alessia Zinzi, Ugo Trama, Annalisa Capuano, Enrica Menditto & Valentina Orlando. (2023) Drug Utilization and Measurement of Medication Adherence: A Real World Study of Psoriasis in Italy. Pharmaceutics 15:12, pages 2647.
Crossref
Hyun-Ji Lee & Miri Kim. (2023) Challenges and Future Trends in the Treatment of Psoriasis. International Journal of Molecular Sciences 24:17, pages 13313.
Crossref